0.00 (0.00%) 1d
MyoKardia Today, Bristol Myers announced it's buying MyoKardia (MYOK-Q) ifor US$13.1 billion cash. MyoKardia makes drugs to fight heart disease and heart conditions, including mavacamten, a drug for which they will file an application in Q1-2021. The stock has gotten really cheap. He loves this deal.

Pharma & Healthcare
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

MyoKardia(MYOK-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for MyoKardia is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

MyoKardia(MYOK-Q) Frequently Asked Questions

What is MyoKardia stock symbol?

MyoKardia is a American stock, trading under the symbol MYOK-Q on the NASDAQ (MYOK). It is usually referred to as NASDAQ:MYOK or MYOK-Q

Is MyoKardia a buy or a sell?

In the last year, there was no coverage of MyoKardia published on Stockchase.

Is MyoKardia a good investment or a top pick?

MyoKardia was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for MyoKardia.

Why is MyoKardia stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is MyoKardia worth watching?

In the last year 0 stock analysts on Stockchase covered MyoKardia. The stock is worth watching.

What is MyoKardia stock price?

On 2020-11-16, MyoKardia (MYOK-Q) stock closed at a price of $224.91.